TE Tirzepatide Editorial

Tool

Tirzepatide First-Month Cost Calculator

Released: · Last reviewed:

Direct answer

This calculator shows what you actually pay on day one — the figure that determines whether you can start — and separates it from the recurring cost that determines whether you can continue. Providers frequently discount the first month, so these two numbers can differ substantially and should be compared separately.

Key takeaways

  • First-month cost and recurring cost are different numbers and should be compared separately.
  • Introductory discounts make the first month a poor guide to ongoing affordability.
  • One-time consultation and setup fees fall entirely in the first month.
  • Comparing providers on first-month cost alone systematically favours discount-led offers.
  • This tool runs in your browser; nothing you enter is transmitted or stored.
Key facts
What it calculatesAmount due at signup versus recurring monthly cost
Why they differIntroductory discounts and one-time fees
Risk of comparing first month onlyFavours discount-led offers with higher renewal rates
Data handlingRuns entirely in your browser
Pair withTrue-cost calculator
Verified
Medical reviewers Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Released 2026-07-22
Updated
Price verified 2026-09-04
Methodology v4.1
Note. This calculator runs entirely in your browser. No values you enter are transmitted or stored.

What you pay to start

Why separate these two numbers?

Because they answer different questions. First-month cost determines whether you can start; recurring cost determines whether you can continue — and continuing is what produces and maintains results. A provider optimising for signups has every incentive to make the first number attractive and the second one less visible.

Comparing providers on the first number alone systematically selects for discount-led offers.

What should you confirm before paying?

The recurring price in writing, including whether the membership rate changes after an introductory period, and whether the medication price itself is introductory. Both are common and both are frequently disclosed only in terms rather than on the pricing page.

Related: True-cost calculator · Cost overview

What do the verified rates look like?

Mondae$114NexLife$115TRYM Health$125Eden$129Sprout Health$149He & She MD$159Bodybuilding Health+$174.67TelePep$214Yucca Health$225Join Josie$233.25Found$239Pallas Health$239Fridays$240Enhance.MD$280Zappy Health$299
The lowest monthly figure each program prints on a standing plan, November 8, 2026. A low monthly figure usually requires prepaying 6 or 12 months; compare the twelve-month cost in the index before choosing.
Data for: Lowest standing monthly figure per program
ProgramAmount
Mondae$114
NexLife$115
TRYM Health$125
Eden$129
Sprout Health$149
He & She MD$159
Bodybuilding Health+$174.67
TelePep$214
Yucca Health$225
Join Josie$233.25
Found$239
Pallas Health$239
Fridays$240
Enhance.MD$280
Zappy Health$299

What does this page cover, and what does it deliberately leave out?

This page addresses Due today, consultation, membership, medication and shipping and renewal, organised around the primary question of tirzepatide first month cost. Each of those elements is treated separately below rather than blended, because they carry different evidence weights and a reader is entitled to know which parts rest on randomised data and which rest on a captured commercial claim or a regulatory document.

Scope of this page and the basis for each element
ElementTreatment hereEvidence basis
Due todayCovered on this pageRegulatory or policy source
ConsultationCovered on this pageRegulatory or policy source
MembershipCovered on this pageRegulatory or policy source
MedicationCovered on this pageRegulatory or policy source
Shipping and renewalCovered on this pageRegulatory or policy source
Individualized clinical instructionDeliberately not coveredBelongs with the provider's own quotation

What are the limits of what this page can tell you?

Every page on this site rests on a specific figures you enter, and that record has boundaries worth stating plainly rather than leaving a reader to discover them. The limitations below are specific to the material presented above.

Specific limitations.
  • The evidence here describes groups, populations, or captured records — it does not describe you, and no page can substitute for the provider's own quotation.
  • Figures carry the date on which they were verified. In a market where terms change frequently, an undated figure functions as a claim about the present that nobody has checked.
  • Elements marked Verification Pending are genuinely unknown to this publication rather than merely omitted for brevity, and should not be inferred from surrounding content.
  • Where a source conflicts with another, this site shows the conflict rather than resolving it, which means some questions are left open on purpose.

What would change the conclusion on this page?

This conclusion is held open to the following evidence:

  • New primary evidence bearing directly on tirzepatide first month cost.
  • A change to FDA labelling affecting any statement made above.
  • A verified correction submitted through the corrections process and accepted on the evidence.
  • A material change to a captured record, including a price, term, or regulatory status.
  • Completion of a verification currently marked pending, which would replace a gap with a stated fact.

Frequently asked questions

Why does the first month cost less?

Providers frequently discount the first month or charge a reduced introductory membership to lower the barrier to signing up.

Which number should I compare between providers?

The recurring cost, since that determines whether you can continue treatment.

Is my data stored?

No. The calculation runs in your browser only.

Where do I find the recurring price?

In the provider's written terms or at checkout — often not on the advertised pricing page.

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Change history

Substantive changes to this page
DateChange
2026-07-22Page published with current dataset snapshot.
2026-09-04Shared cost components and disclosures rebuilt from the 2026-09-04 dataset (NexLife September 2026 card re-read live; Yucca Health and a program since removed from this site added; NexLife disclosed as a commercial partner, labelled where it appears).
2026-11-08Updated for November 2026: prices, methodology labels (v4.1) and disclosures brought to the November 8, 2026 dataset; researcher and both medical reviewers named.

Dates change only for substantive edits, never for cosmetic changes. Corrections: corrections policy.

What else is in this section?